标题
Selective reactivation of STING signaling to target Merkel cell carcinoma
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume -, Issue -, Pages 201919690
出版商
Proceedings of the National Academy of Sciences
发表日期
2020-06-02
DOI
10.1073/pnas.1919690117
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- STING-mediated disruption of calcium homeostasis chronically activates ER stress and primes T cell death
- (2019) Jianjun Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Durable Tumor Regression and Overall Survival in Patients With Advanced Merkel Cell Carcinoma Receiving Pembrolizumab as First-Line Therapy
- (2019) Paul Nghiem et al. JOURNAL OF CLINICAL ONCOLOGY
- Harnessing innate immunity in cancer therapy
- (2019) Olivier Demaria et al. NATURE
- An overview on Vadimezan (DMXAA): The vascular disrupting agent
- (2018) Amir Daei Farshchi Adli et al. Chemical Biology & Drug Design
- Targeting Merkel Cell Carcinoma by Engineered T Cells Specific to T-Antigens of Merkel Cell Polyomavirus
- (2018) Ioannis Gavvovidis et al. CLINICAL CANCER RESEARCH
- Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics
- (2018) Kelly G. Paulson et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Efficacy and Safety of First-line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma
- (2018) Sandra P. D’Angelo et al. JAMA Oncology
- STING Signaling Promotes Apoptosis, Necrosis, and Cell Death: An Overview and Update
- (2018) Song Liu et al. MEDIATORS OF INFLAMMATION
- Design of amidobenzimidazole STING receptor agonists with systemic activity
- (2018) Joshi M. Ramanjulu et al. NATURE
- Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity
- (2018) Kelsey E. Sivick et al. Cell Reports
- Disease-associated mutations identify a novel region in human STING necessary for the control of type I interferon signaling
- (2017) Isabelle Melki et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes
- (2017) Silvia Cerboni et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Cutting Edge: Activation of STING in T Cells Induces Type I IFN Responses and Cell Death
- (2017) Bridget Larkin et al. JOURNAL OF IMMUNOLOGY
- Cytoplasmic chromatin triggers inflammation in senescence and cancer
- (2017) Zhixun Dou et al. NATURE
- Signalling strength determines proapoptotic functions of STING
- (2017) Muhammet F. Gulen et al. Nature Communications
- Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis
- (2017) Jingwei Cheng et al. PLoS Pathogens
- Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival
- (2017) Natalie J. Miller et al. Cancer Immunology Research
- A STING Agonist Given with OX40 Receptor and PD-L1 Modulators Primes Immunity and Reduces Tumor Growth in Tolerized Mice
- (2017) Jeremy B. Foote et al. Cancer Immunology Research
- The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression
- (2017) Julia M. Weiss et al. OncoImmunology
- Merkel cell carcinoma
- (2017) Jürgen C. Becker et al. Nature Reviews Disease Primers
- Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
- (2017) Cathrin Ritter et al. Scientific Reports
- Familial chilblain lupus due to a gain-of-function mutation in STING
- (2016) Nadja König et al. ANNALS OF THE RHEUMATIC DISEASES
- PD-1 blockade: a therapeutic option for treatment of metastatic Merkel cell carcinoma
- (2016) J.K. Winkler et al. BRITISH JOURNAL OF DERMATOLOGY
- PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma
- (2016) Paul T. Nghiem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deregulation of STING Signaling in Colorectal Carcinoma Constrains DNA Damage Responses and Correlates With Tumorigenesis
- (2016) Tianli Xia et al. Cell Reports
- Merkel cell polyomavirus infection and Merkel cell carcinoma
- (2016) Wei Liu et al. Current Opinion in Virology
- Risk of Merkel Cell Carcinoma After Solid Organ Transplantation
- (2015) C. A. Clarke et al. JNCI-Journal of the National Cancer Institute
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade
- (2015) Juan Fu et al. Science Translational Medicine
- Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
- (2015) Leticia Corrales et al. Cell Reports
- Risk of Merkel Cell Carcinoma After Solid Organ Transplantation
- (2015) C. A. Clarke et al. JNCI-Journal of the National Cancer Institute
- CD8+ Lymphocyte Intratumoral Infiltration as a Stage-Independent Predictor of Merkel Cell Carcinoma Survival
- (2014) Kelly G. Paulson et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Inherited STING-activating mutation underlies a familial inflammatory syndrome with lupus-like manifestations
- (2014) Nadia Jeremiah et al. JOURNAL OF CLINICAL INVESTIGATION
- Activated STING in a Vascular and Pulmonary Syndrome
- (2014) Yin Liu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inflammation-driven carcinogenesis is mediated through STING
- (2014) Jeonghyun Ahn et al. Nature Communications
- Binding-Pocket and Lid-Region Substitutions Render Human STING Sensitive to the Species-Specific Drug DMXAA
- (2014) Pu Gao et al. Cell Reports
- Structure-Function Analysis of STING Activation by c[G(2′,5′)pA(3′,5′)p] and Targeting by Antiviral DMXAA
- (2013) Pu Gao et al. CELL
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- Vascular E-Selectin Expression Correlates with CD8 Lymphocyte Infiltration and Improved Outcome in Merkel Cell Carcinoma
- (2013) Olga K. Afanasiev et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumor-Specific T Cells in Human Merkel Cell Carcinomas: A Possible Role for Tregs and T-Cell Exhaustion in Reducing T-Cell Responses
- (2013) Mitra Dowlatshahi et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Tumor Infiltrating Immune Cells and Outcome of Merkel Cell Carcinoma: A Population-Based Study
- (2012) H. Sihto et al. CLINICAL CANCER RESEARCH
- Different affinity windows for virus and cancer-specific T-cell receptors: Implications for therapeutic strategies
- (2012) Milos Aleksic et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- RNA-Seq Analysis Reveals Different Dynamics of Differentiation of Human Dermis- and Adipose-Derived Stromal Stem Cells
- (2012) Kersti Jääger et al. PLoS One
- Tumor-infiltrating lymphocytes and outcome in Merkel cell carcinoma, a virus-associated cancer
- (2012) Harri Sihto et al. OncoImmunology
- Merkel Cell Carcinoma: A Virus-Induced Human Cancer
- (2011) Yuan Chang et al. Annual Review of Pathology-Mechanisms of Disease
- Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and Blood
- (2011) J. G. Iyer et al. CLINICAL CANCER RESEARCH
- Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer
- (2011) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Transcriptome-Wide Studies of Merkel Cell Carcinoma and Validation of Intratumoral CD8+ Lymphocyte Invasion As an Independent Predictor of Survival
- (2011) Kelly G. Paulson et al. JOURNAL OF CLINICAL ONCOLOGY
- Immunobiology of Merkel Cell Carcinoma: Implications for Immunotherapy of a Polyomavirus-Associated Cancer
- (2011) Shailender Bhatia et al. Current Oncology Reports
- The emerging role of CXCL10 in cancer (Review)
- (2011) MINGLI LIU et al. Oncology Letters
- Phase II Study on the Addition of ASA404 (Vadimezan; 5,6-Dimethylxanthenone-4-Acetic Acid) to Docetaxel in CRMPC
- (2010) R. Pili et al. CLINICAL CANCER RESEARCH
- Molecular pathogenesis of Merkel cell carcinoma
- (2009) Roland Houben et al. EXPERIMENTAL DERMATOLOGY
- Merkel cell carcinoma demographics, morphology, and survival based on 3870 cases: a population based study
- (2009) Jorge Albores-Saavedra et al. JOURNAL OF CUTANEOUS PATHOLOGY
- Clinical Factors Associated With Merkel Cell Polyomavirus Infection in Merkel Cell Carcinoma
- (2009) Harri Sihto et al. JNCI-Journal of the National Cancer Institute
- Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features
- (2008) Michelle Heath et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
- Control of HIV-1 immune escape by CD8 T cells expressing enhanced T-cell receptor
- (2008) Angel Varela-Rohena et al. NATURE MEDICINE
- Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma
- (2008) H. Feng et al. SCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now